Celvita Overview
- Year Founded
-
2023
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Celvita General Information
Description
Operator of a cell banking facility based in Hong Kong. The joint venture provides cryopreservation services of peripheral blood immune cells from young and adult healthy donors before the onset of potential diseases and considerable loss of functionality with age, thereby enabling customers by providing sources of healthy immune cells for future disease treatments, including cancers and aging.
Contact Information
Corporate Office
- Hong Kong
Corporate Office
- Hong Kong
Celvita Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Celvita Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Celvita FAQs
-
When was Celvita founded?
Celvita was founded in 2023.
-
Where is Celvita headquartered?
Celvita is headquartered in Hong Kong.
-
What industry is Celvita in?
Celvita’s primary industry is Other Healthcare Services.
-
Is Celvita a private or public company?
Celvita is a Private company.
-
What is Celvita’s current revenue?
The current revenue for Celvita is .
-
Who are Celvita’s investors?
Arbele and CMA Testing have invested in Celvita.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process